WAIVER WITH RESPECT TO 8% FIXED PROMISSORY NOTEWaiver • January 20th, 2021 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations
This Waiver, dated as of January 13, 2021 (this “Waiver”), is made by White Lion Capital LLC, a Nevada limited liability company (the “Investor”), in favor of RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company” and, together with the Investor, the “Parties”). Capitalized terms used and not defined herein have the respective meanings assigned to them in the Note (as defined below).
WAIVER AND AMENDMENT TO CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • January 20th, 2021 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
This Waiver and Amendment to Convertible Promissory Note (this “Waiver and Amendment”), dated as of January 13, 2021, by and between FirstFire Global Opportunities Fund LLC, a Delaware limited liability company (the “Investor”) and RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company” and, together with the Investor, the “Parties”). Capitalized terms used and not defined herein have the respective meanings assigned to them in the Note (as defined below).
